Consistently, here, we found that 30.3% of women with a history of GDM without insulin treatment during pregnancy and 42.8% of GDM patients with insulin treatment during pregnancy as opposed to 17.8% of women with normoglycemic pregnancies had developed prediabetes at the 5-year follow-up (Visit 2). This evidence concerns the gene INS and prediabetes syndrome.